STEROID COMPLEXATION BY CYCLOPHANE RECEPTORS IN AQUEOUS-SOLUTION - SUBSTRATE SELECTIVITY, ENTHALPIC DRIVING-FORCE FOR CAVITY INCLUSION, AND ENTHALPY-ENTROPY COMPENSATION

被引:52
作者
PETERSON, BR [1 ]
WALLIMANN, P [1 ]
CARCANAGUE, DR [1 ]
DIEDERICH, F [1 ]
机构
[1] ETH ZENTRUM, ORGAN CHEM LAB, CH-8092 ZURICH, SWITZERLAND
基金
美国国家科学基金会;
关键词
D O I
10.1016/0040-4020(94)00905-A
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
The synthesis, characterization, and steroid binding properties of two novel cyclophane receptors shaped by two naphthylphenylmethane spacers are reported. Cyclophane 1 forms inclusion complexes with bile acids, corticoids, and androgenic steroids in D2O/CD3OD 1:1. Specific functional group solvation effects generate high binding selectivity in the series of structurally similar bile acid derivatives: the complex of lithocholic acid is approximate to 2 kcal/mol more stable than the complex of deoxycholic acid. Steroid complexation by I is enthalpically driven, and complexation thermodynamics follows a strong enthalpy-entropy compensation relationship. Cyclophane 2 with 4 quaternary ammonium centers shows a much higher non-aggregated water-solubility than I with its two quaternary centers and forms stable steroid inclusion complexes in pure water. Complexes of anionic steroids with 2 are stabilized by both apolar interactions and ion pairing.
引用
收藏
页码:401 / 421
页数:21
相关论文
共 63 条
[1]   COMPLEXATION OF STEROID-HORMONES WITH CYCLODEXTRIN DERIVATIVES - SUBSTITUENT EFFECTS OF THE GUEST MOLECULE ON SOLUBILITY AND STABILITY IN AQUEOUS-SOLUTION [J].
ALBERS, E ;
MULLER, BW .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (08) :756-761
[2]  
BLOKZIJL W, 1993, ANGEW CHEM INT EDIT, V32, P1545, DOI 10.1002/anie.199315451
[3]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[4]   HOW LDL RECEPTORS INFLUENCE CHOLESTEROL AND ATHEROSCLEROSIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENTIFIC AMERICAN, 1984, 251 (05) :58-&
[5]  
CARCANAGUE DR, 1990, ANGEW CHEM INT EDIT, V29, P769
[6]  
CARCANAGUE DR, 1990, ANGEW CHEM, V102, P836
[7]  
CASDORPH HR, 1976, LIPID PHARM, V2, P222
[8]  
CHUN IK, 1993, INT J PHARM, V96, P91
[9]  
CLAUDY P, 1991, J THERM ANAL, V37, P2497
[10]   CYCLODEXTRIN ADAMANTANECARBOXYLATE INCLUSION COMPLEXES - STUDIES OF THE VARIATION IN CAVITY SIZE [J].
CROMWELL, WC ;
BYSTROM, K ;
EFTINK, MR .
JOURNAL OF PHYSICAL CHEMISTRY, 1985, 89 (02) :326-332